Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
CytoDyn Inc. stock logo
CYDY
CytoDyn
$0.24
+9.3%		$0.22
$0.18
▼
$0.40
$298.58M1.181.29 million shs2.42 million shs
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$12.34
C$12.38
C$4.55
▼
C$13.93
C$990.56MN/A219,805 shsN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
$1.77
$1.77
$1.64
▼
$2.74
$1.07B0.372,185 shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
CytoDyn Inc. stock logo
CYDY
CytoDyn
+3.24%+9.99%+9.49%-35.63%-27.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
0.00%0.00%0.00%+14.52%+54.64%
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
CytoDyn Inc. stock logo
CYDY
CytoDyn
$0.24
+9.3%		$0.22
$0.18
▼
$0.40
$298.58M1.181.29 million shs2.42 million shs
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$12.34
C$12.38
C$4.55
▼
C$13.93
C$990.56MN/A219,805 shsN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
$1.77
$1.77
$1.64
▼
$2.74
$1.07B0.372,185 shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
CytoDyn Inc. stock logo
CYDY
CytoDyn
+3.24%+9.99%+9.49%-35.63%-27.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
0.00%0.00%0.00%+14.52%+54.64%
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00
N/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
0.00
N/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
2.00
HoldN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CYDY, VEGPF, CNTTF, and GLASF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/15/2026
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
(Data available from 8/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$15.96M0.00N/AN/AN/ANaN
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/AN/A$0.00 per share65.07($0.08) per shareN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
$244.76M4.37$0.28 per share6.33$1.16 per share1.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A$0.07137.18N/AN/AN/AN/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
$3.74M-$0.03N/AN/AN/AN/AN/A-182.93%8/26/2026 (Estimated)
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
$157.16M$0.266.8117.70N/AN/AN/AN/AN/A

Latest CYDY, VEGPF, CNTTF, and GLASF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/26/2026Q4 2026
CytoDyn Inc. stock logo
CYDY
CytoDyn
-$0.05N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/AN/AN/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/A
0.37
0.37
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.08%
CytoDyn Inc. stock logo
CYDY
CytoDyn
5.06%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/A

Insider Ownership

CompanyInsider Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
1.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A105.61 millionN/ANot Optionable
CytoDyn Inc. stock logo
CYDY
CytoDyn
201.38 billion1.36 billionNot Optionable
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
36280.27 millionN/ANot Optionable
Vectura Group plc stock logo
VEGPF
Vectura Group
502604.26 millionN/ANot Optionable

Recent News About These Companies

Philip Morris closes on the sale of Vectura Group
January 2, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/philip-morris-closes-on-the-sale-of-vectura-group/ar-AA1wQN6L
M&A News: Philip Morris (NYSE:PM) Will Sell Vectura for $198M
September 17, 2024  |  msn.comhttps://www.msn.com/en-us/money/topstocks/m-a-news-philip-morris-nyse-pm-will-sell-vectura-for-198m/ar-AA1qJ9cR
Vectura and Hikma to develop US asthma generic
August 20, 2024  |  pharmaphorum.comP
European Stocks See Mixed Session as U.K.'s FTSE Leads
January 16, 2023  |  thestreet.comhttps://www.thestreet.com/markets/european-stocks-see-mixed-session-as-u-k-s-ftse-leads-14129201
VECTURA GROUP LS -,000271 (V4TA.BE)
January 15, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/V4TA.BE/history/
Vectura Group PLC (V4TA.BE)
January 9, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/V4TA.BE/history?p=V4TA.BE
Results for 'Vectura-Fertin Pharma'
October 11, 2022  |  afaqs.comA
Vectura Group (OTC:VEGPF), Short Interest Report
July 18, 2022  |  benzinga.comhttps://www.benzinga.com/quote/VEGPF/short-interest
Carlyle stays in race for Vectura
August 27, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/carlyle-stays-race-vectura-145301112.html?.tsrc=rss
Form 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210826
August 27, 2021  |  finance.yahoo.comhttps://finance.yahoo.com/news/form-8-3-form-8-093300735.html?.tsrc=rss
Philip Morris chief attacks critics as Vectura bid tests investors
August 20, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/philip-morris-chief-attacks-critics-164642627.html?.tsrc=rss
Markets: FTSE inches to new post-pandemic high as Vectura takeover draws closer
August 13, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/stock-market-13-august-ftse-cac-dax-sp500-dow-jones-nasdaq-vectura-philip-morris-takeover-marlboro-disney-adidas-075223887.html?.tsrc=rss
Vectura auction called off after Carlyle declines to beat Philip Morris bid
August 10, 2021  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/vectura-auction-called-off-carlyle-172600705.html?.tsrc=rss
UPDATE 1-Vectura takeover battle could slip into auction - UK regulator
August 9, 2021  |  finance.yahoo.comhttps://finance.yahoo.com/news/1-vectura-takeover-battle-could-091519978.html?.tsrc=rss
Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring
August 9, 2021  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/news/philip-morris-carlyle-could-fight-091841300.html?.tsrc=rss

New MarketBeat Followers Over Time

Media Sentiment Over Time

CannTrust stock logo

CannTrust OTCMKTS:CNTTF

CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.

CytoDyn stock logo

CytoDyn OTCMKTS:CYDY

$0.24 +0.02 (+9.32%)
As of 03:59 PM Eastern

CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Glass House Brands stock logo

Glass House Brands OTCMKTS:GLASF

C$12.34 0.00 (0.00%)
As of 08/24/2026

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.

Vectura Group stock logo

Vectura Group OTCMKTS:VEGPF

$1.77 0.00 (0.00%)
As of 11/1/2021

Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas